Benitec Biopharma Inc. (BNTC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
13.70
-0.10 (-0.72%)
At close: Sep 26, 2025, 3:59 PM
13.70
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Benitec Biopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-37.92M -21.75M -19.56M -18.21M -13.88M
Depreciation & Amortization
396K 343K 381K 392K 424K
Stock-Based Compensation
17.43M 830K 452K 870K 634K
Other Working Capital
-548K 409K 714K 1.04M 8K
Other Non-Cash Items
-764K 1K 717K 10K -16K
Deferred Income Tax
n/a n/a -714K n/a n/a
Change in Working Capital
-2.73M 1.17M 714K 1.04M 8K
Operating Cash Flow
-23.59M -19.4M -18.01M -15.9M -12.83M
Capital Expenditures
-18K -179K -1K -13K -221K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
-18K -179K -1K -13K -221K
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -5.89M -1.87M n/a -3.23M
Financial Cash Flow
70.48M 68.03M 16.02M n/a 22.52M
Net Cash Flow
46.93M 48.44M -1.59M -15.71M 9.97M
Free Cash Flow
-23.61M -19.58M -18.01M -15.91M -13.05M